
Avalo Therapeutics: Sharing Innovations and Progress at Oppenheimer’s 35th Annual Healthcare and Life Sciences Conference
Avalo Therapeutics: Garry A. Neil’s Presentation at Oppenheimer Healthcare Conference On February 11, 2025, Avalo Therapeutics, Inc., a biotechnology company specializing in the treatment of immune dysregulation, made an important announcement. The company’s CEO and Chairman, Garry A. Neil, M.D., was scheduled to present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference at…